Suchergebnisse - "Tian, Fan"

PubPharm (99)

1

Insight to the Catalytic Activity of Atomically Precise Ag4Ni2 Nanoclusters on Silicon Carbide for Nitroarene Reduction

enthalten in: Inorganic chemistry | 2024

von Xiao, Y. | Huang, X. | Li, H. | +4

2

Revealing spatiotemporal inequalities, hotspots, and determinants in healthcare resource distribution : insights from hospital beds panel data in 2308 Chinese counties

enthalten in: BMC public health | 2024

von Song, C. | Fang, L. | Xie, M. | +8

3

Comparative transcriptomics and proteomics analysis of the symbiotic germination of Paphiopedilum barbigerum with Epulorhiza sp. FQXY019

enthalten in: Frontiers in microbiology | 2024

von Tian, F. | Wang, J. | Ding, F. | +5

4

Symbiotic seed germination and seedling growth of mycorrhizal fungi in Paphiopedilum hirsutissimun (Lindl.Ex Hook.) Stein from China

enthalten in: Plant signaling & behavior | 2023

von Tian, F. | Wang, J. | Bai, X. | +3

5

Catalytic Hydrogenation of Nitroarenes over Ag33 Nanoclusters : The Ligand Effect

enthalten in: Inorganic chemistry | 2023

von Yuan, J. | Huang, X. | Zhang, W. | +4

6

A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS

enthalten in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2023

von Newsome, S. | Tian, F. | Shoemaker, T. | +9

7

Causal effects of maternal exposure to PM2.5 during pregnancy on depression symptoms in adolescence : Identifying vulnerable windows and subpopulations in a national cohort study

enthalten in: Environmental research | 2023

von Ju, K. | Lu, L. | Wang, Z. | +5

8

A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS

enthalten in: Neurotherapeutics | 2023

von Newsome, S. | Tian, F. | Shoemaker, T. | +9

9

A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS

enthalten in: Neurotherapeutics | 2023

von Newsome, S. | Tian, F. | Shoemaker, T. | +9

10

A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS

enthalten in: NeuroRX | 2023

von Newsome, S. | Tian, F. | Shoemaker, T. | +9

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]